• Optimized hiPSC Platelet Differentiation: Protocols & Src In

  2026-07-14

  This study introduces an optimized, cost-effective protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs) by combining higher embryoid body input, refined media, and small-molecule modulators—including Src tyrosine kinases inhibitors. The approach significantly boosts platelet yield and maturation, with implications for scalable regenerative medicine and cell therapy.

• Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-07-13

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient, high-yield synthesis of randomly Cy3-labeled RNA probes for sensitive fluorescence-based detection. It is designed for research workflows such as in situ hybridization and Northern blotting, but is not validated for diagnostic, therapeutic, or clinical use.

• Mavorixafor Phase 3 Trial: Progress in WHIM Syndrome Therapy

  2026-07-13

  The recent phase 3 study of mavorixafor provides the first robust evidence that targeted CXCR4 antagonism can significantly increase neutrophil and lymphocyte counts in WHIM syndrome, a rare immunodeficiency. These findings establish a new clinical benchmark for disease management and highlight evolving methodological standards for clinical trials in ultra-rare conditions.

• Iron Stress Alters Enterocyte Metabolism and Inflammatory Re

  2026-07-12

  Navazesh and Ji's 2025 study reveals that both iron deficiency and excess profoundly reprogram enterocyte metabolism, affecting proliferation, inflammation, and key metabolic pathways. Their work provides mechanistic insight into how iron status influences intestinal epithelial cell function, with implications for nutritional interventions and disease research.

• Anlotinib Hydrochloride: Selective VEGFR2 Inhibition in Angi

  2026-07-10

  This article reviews the preclinical characterization of anlotinib hydrochloride, a highly selective multi-target tyrosine kinase inhibitor, with a focus on its potent inhibition of VEGFR2-mediated angiogenesis. The findings highlight its strong anti-angiogenic properties, broad in vivo antitumor efficacy, and implications for translational cancer research.

• Chloramphenicol in Plasmid Selection: Protocols & Troublesho

  2026-07-09

  Chloramphenicol empowers molecular biologists with precise control in plasmid selection assays, especially when tracking multidrug-resistant genes. Discover advanced workflows and troubleshooting strategies that maximize reproducibility, drawing on the latest epidemiological insights and high-purity supply from APExBIO.

• CPI-613: Applied Workflows for Tumor Cell Metabolism Studies

  2026-07-09

  CPI-613, also known as 6,8-bis(benzylsulfanyl)octanoic acid, enables precise disruption of tumor mitochondrial metabolism for apoptosis and tumor cell metabolism studies. This article details practical workflows, protocol parameters, and troubleshooting insights to maximize reproducibility and insight in cancer research models.

• PPP1R3G/PP1γ-Mediated RIPK1 Activation Drives Cell Death Pat

  2026-07-08

  This study elucidates how the phosphatase complex PPP1R3G/PP1γ directly regulates the activation of RIPK1 by dephosphorylating inhibitory sites, thereby promoting apoptosis and necroptosis. These findings clarify a critical control point in cell death and inflammation, with practical implications for NF-κB pathway and cytokine modulation research.

• STING-Mediated IFN-Like Antiviral Response in Marine Inverte

  2026-07-08

  This study uncovers a unique DNA-sensing mechanism in shrimp, revealing that STING directly detects viral DNA and initiates an interferon-like antiviral response. These findings illuminate the evolutionary origins of cytosolic nucleic acid sensing and have important implications for understanding innate immunity in invertebrates.

• Catalpol Inhibits Liver Fibrosis by Targeting Glycolysis via

  2026-07-07

  This study reveals that catalpol can attenuate liver fibrosis by directly inhibiting aerobic glycolysis in hepatic stellate cells through the EphA2/FAK/Src pathway. The findings provide mechanistic insight into fibrotic disease modulation and point toward metabolic targeting as a therapeutic strategy in hepatic fibrosis.

• A40926: From Fermentation to Advanced Gram-Positive Assays

  2026-07-07

  Explore A40926, a potent dalbavancin precursor, through the lens of its unique biosynthesis, mechanism, and benchmark-setting anti-Neisseria activity. This article delivers practical insights for antibiotic researchers, moving beyond workflow summaries to dissect evidence, protocol design, and assay optimization.

• M344: Advanced Epigenetic Control for Cancer and HIV Researc

  2026-07-06

  M344 is a potent histone deacetylase inhibitor enabling precise epigenetic modulation and innovative study designs in cancer and HIV latency research. This article delivers deep scientific insights, practical assay parameters, and a critical comparison with alternative strategies, offering researchers a distinctive resource for experimental optimization.

• Optimizing Assays with EZ Cap™ Firefly Luciferase mRNA

  2026-07-06

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure empowers high-sensitivity, reproducible bioluminescent assays by combining superior stability and translation efficiency. This guide delivers practical workflows, advanced applications, and troubleshooting tips to unlock its full potential in mRNA delivery and in vivo imaging.

• Hyperthermia-Induced BRCA2 Reduction Sensitizes Ovarian Canc

  2026-07-05

  Mei et al. demonstrate that hyperthermia-mediated reduction of BRCA2 protein levels in BRCA2-proficient ovarian carcinoma cells enhances sensitivity to PARP inhibitors such as Niraparib. This finding suggests a promising strategy to overcome intrinsic resistance in BRCA2-proficient ovarian cancers and informs future combination therapy research.

• CXCR4-Mediated Autophagy Sustains EBV Latency in Gastric Car

  2026-07-04

  This study uncovers how CXCR4 upregulation, driven by EBV latent protein LMP2A, promotes autophagy and maintains Epstein-Barr virus (EBV) latency in EBV-associated gastric carcinoma (EBVaGC). These findings reveal mechanistic links between viral persistence, cell cycle regulation, and apoptosis resistance, suggesting new intervention targets in EBV-driven tumorigenesis.

459 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page